Association of Nef with the human immunodeficiency virus type 1 core.
about
Visualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy.Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factorHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchHIV-1 capsid: the multifaceted key player in HIV-1 infectionStructural and functional comparisons of retroviral envelope protein C-terminal domains: still much to learnHIV-1 protease and reverse transcriptase control the architecture of their nucleocapsid partnerCharacterization of Hepatitis C Virus Core Protein Multimerization and Membrane Envelopment: Revelation of a Cascade of Core-Membrane InteractionsFates of retroviral core components during unrestricted and TRIM5-restricted infectionLentivirus Nef specifically activates Pak2.Primate TRIM5 proteins form hexagonal nets on HIV-1 capsids.Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivityHuman immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity.C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.Isolation of human immunodeficiency virus type 1 cores: retention of Vpr in the absence of p6(gag).CCR5 signal transduction in macrophages by human immunodeficiency virus and simian immunodeficiency virus envelopesRole of human immunodeficiency virus type 1 integrase in uncoating of the viral core.Chimeric human immunodeficiency virus type 1 virions that contain the simian immunodeficiency virus nef gene are cyclosporin A resistant.Nef enhances human immunodeficiency virus type 1 infectivity resulting from intervirion fusion: evidence supporting a role for Nef at the virion envelope.Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.Human immunodeficiency virus type 1 Nef functions at the level of virus entry by enhancing cytoplasmic delivery of virions.Restoration of wild-type infectivity to human immunodeficiency virus type 1 strains lacking nef by intravirion reverse transcription.Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication.A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.Treatment of human immunodeficiency virus type 1 virions depleted of cyclophilin A by natural endogenous reverse transcription restores infectivityGenetic analysis of the localization of APOBEC3F to human immunodeficiency virus type 1 virion cores.Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycleHIV-1 Env and Nef Cooperatively Contribute to Plasmacytoid Dendritic Cell Activation via CD4-Dependent MechanismsSignals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction.The trinity of the cortical actin in the initiation of HIV-1 infectionVirus-producing cells determine the host protein profiles of HIV-1 virion cores.Visualization of the intracellular behavior of HIV in living cells.Cell factors stimulate human immunodeficiency virus type 1 reverse transcription in vitroHuman T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation.Tuning of AKT-pathway by Nef and its blockade by protease inhibitors results in limited recovery in latently HIV infected T-cell line.Atomic force microscopy investigation of human immunodeficiency virus (HIV) and HIV-infected lymphocytes.Small-molecule inhibition of human immunodeficiency virus type 1 replication by specific targeting of the final step of virion maturation.Chimeric human immunodeficiency virus type 1 (HIV-1) virions containing HIV-2 or simian immunodeficiency virus Nef are resistant to cyclosporine treatment.Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
P2860
Q22241754-840A91AB-7915-4E99-9364-4BC15C9C6602Q24547409-45E72234-6EC3-4BFC-9A8C-5B071A848E00Q26746070-4998A7E3-651F-4766-A3F2-4F9153B71676Q26801145-8E7EAF7D-221C-49E1-85CC-08EA9666D994Q26862369-003AA2F2-31B6-4396-AF63-D84C87EF408CQ27302871-831AB6F7-81FE-4FCE-B97B-7BA1FD2372A9Q27489695-2B603448-CD08-485C-8844-9F34AD887B8EQ28487732-99780CFD-DC79-4BEE-A641-B16828E3EA16Q28647353-0CBEBB79-FEC5-4238-98F9-D0CB22A9BCC6Q30276687-B4A20DF9-ECA5-4E09-A9D8-AB25D31E169BQ30307077-BC38A0F9-1309-4E7F-9034-277D3B0AFFCAQ30312050-E8DA98E1-DAC4-4CFE-BD0C-D6755615371FQ30422545-79F82671-A222-4A5A-B3DD-BFDDC6FF393FQ33753132-9BF83634-F7E4-4C0A-B448-0D891DE3AE42Q33807166-6AFFC1BE-DD74-4152-B4D1-606D1CC25995Q33807693-CB019FB7-2F0A-4EB8-94CA-AF2742D1B580Q33826918-A2963277-4349-4A9B-8217-F390767AC04CQ33834565-EDE71B92-A175-4468-AF2D-51FC37B0920EQ33842252-1B238CA3-1D54-46FF-8330-B0A3B04DC78BQ33845811-95D5C3F6-65F6-4C2F-BF8A-D0FC6DD3F21BQ33852465-EDDD47CD-6483-44F3-BD57-BC815E12896AQ33866230-CB7D5AA8-115A-43F2-B97E-5A5F98669196Q33869997-20F5ECFF-FC8D-4A82-91A0-C3EBF42C770CQ34364648-55FC2E06-2F34-4A13-9981-A975121C488AQ34434813-C7497884-90C5-4813-9031-81B2E07C4BE2Q34782333-96686228-0E46-4BC1-BB13-2CD4C129323CQ35115703-3068E8D7-59DA-421B-A20C-03D8F22F8A81Q35819383-579A7E58-2F45-46EB-BAFA-CA11641CF077Q35861175-1A630FB3-3B06-4893-970D-43954B4EC762Q35956555-B42D718D-F327-49E5-B8B6-59EE3D09BD61Q36156531-039BF776-4199-4168-889D-CAAFF8C49AEAQ36204700-E5A9DDF2-B292-434E-ACAE-3156A28E0778Q36323740-C47DB082-9D34-499C-8EE1-1526D8A4170DQ36424184-96A022AC-6845-49CD-B676-E21D7036ED4DQ36474292-95083901-5AB2-4A49-85BD-7DBE3A739E61Q36796376-3D3ACEC0-D5FB-4E1D-AC9D-2C98EE2853FFQ36890537-EE50EC4E-D130-410E-89FD-64A665139077Q36944553-B619F059-36A3-4BB3-AFC0-49B0877E8ED1Q36959665-F081962B-744C-4D6B-82C2-78B863D5A146Q36974763-E8BE1BE8-1623-418E-871E-5F341974847C
P2860
Association of Nef with the human immunodeficiency virus type 1 core.
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Association of Nef with the human immunodeficiency virus type 1 core.
@ast
Association of Nef with the human immunodeficiency virus type 1 core.
@en
type
label
Association of Nef with the human immunodeficiency virus type 1 core.
@ast
Association of Nef with the human immunodeficiency virus type 1 core.
@en
prefLabel
Association of Nef with the human immunodeficiency virus type 1 core.
@ast
Association of Nef with the human immunodeficiency virus type 1 core.
@en
P2093
P2860
P1433
P1476
Association of Nef with the human immunodeficiency virus type 1 core.
@en
P2093
P2860
P304
P577
1999-10-01T00:00:00Z